Cargando…

The challenge of developing universal vaccines

Antigenic variability of immunodominant antigens is a common mechanism used by pathogens to escape the immune response. Frequently, the proposed solution is a universal vaccine based on conserved antigens present on all strains of the pathogen. Indeed, a lot of progress has been made in the developm...

Descripción completa

Detalles Bibliográficos
Autor principal: Rappuoli, Rino
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Faculty of 1000 Ltd 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3155208/
https://www.ncbi.nlm.nih.gov/pubmed/21904572
http://dx.doi.org/10.3410/M3-16
_version_ 1782210093145653248
author Rappuoli, Rino
author_facet Rappuoli, Rino
author_sort Rappuoli, Rino
collection PubMed
description Antigenic variability of immunodominant antigens is a common mechanism used by pathogens to escape the immune response. Frequently, the proposed solution is a universal vaccine based on conserved antigens present on all strains of the pathogen. Indeed, a lot of progress has been made in the development of vaccines that induce broad immune responses. However, truly universal vaccines are not easy to produce and still face many challenges, mostly because in those pathogens that use antigenic variability to escape the immune response, conserved antigens have been selected by evolution to be poorly immunogenic. This review describes the progress made towards the development of vaccines inducing broad protection against Neisseria meningitidis, influenza, HIV, and Candida and the challenges of developing truly universal vaccines.
format Online
Article
Text
id pubmed-3155208
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Faculty of 1000 Ltd
record_format MEDLINE/PubMed
spelling pubmed-31552082011-09-08 The challenge of developing universal vaccines Rappuoli, Rino F1000 Med Rep Review Article Antigenic variability of immunodominant antigens is a common mechanism used by pathogens to escape the immune response. Frequently, the proposed solution is a universal vaccine based on conserved antigens present on all strains of the pathogen. Indeed, a lot of progress has been made in the development of vaccines that induce broad immune responses. However, truly universal vaccines are not easy to produce and still face many challenges, mostly because in those pathogens that use antigenic variability to escape the immune response, conserved antigens have been selected by evolution to be poorly immunogenic. This review describes the progress made towards the development of vaccines inducing broad protection against Neisseria meningitidis, influenza, HIV, and Candida and the challenges of developing truly universal vaccines. Faculty of 1000 Ltd 2011-08-01 /pmc/articles/PMC3155208/ /pubmed/21904572 http://dx.doi.org/10.3410/M3-16 Text en © 2011 Faculty of 1000 Ltd http://creativecommons.org/licenses/by-nc/3.0/legalcode This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. You may not use this work for commercial purposes
spellingShingle Review Article
Rappuoli, Rino
The challenge of developing universal vaccines
title The challenge of developing universal vaccines
title_full The challenge of developing universal vaccines
title_fullStr The challenge of developing universal vaccines
title_full_unstemmed The challenge of developing universal vaccines
title_short The challenge of developing universal vaccines
title_sort challenge of developing universal vaccines
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3155208/
https://www.ncbi.nlm.nih.gov/pubmed/21904572
http://dx.doi.org/10.3410/M3-16
work_keys_str_mv AT rappuolirino thechallengeofdevelopinguniversalvaccines
AT rappuolirino challengeofdevelopinguniversalvaccines